Intelligence · Drug directory
Pipeline & Investigational Drugs
Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
Quick answer
Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
-
etelcalcetide hydrochloride
PARSABIV
-
ethanol (90 per cent) (use as additive only)
NULL
-
ethanol (96 per cent) (use as additive only)
NULL
-
ether solvent (use as additive only)
NULL
-
eucalyptus oil (use as additive only)
NULL
-
evocalcet
ORKEDIA INITIAL APPROVAL
-
eye drops containing cocaine hydrochloride
NULL
-
eye drops, other
NULL
-
eye lotions
NULL
-
ezetimibe / rosuvastatin calcium
ROSUZET
-
favipiravir
AVIGAN
-
filgotinib maleate
JYSELECA
-
flupentixol decanoate
FLUANXOL DEPOT
-
formaldehyde solution
NULL
-
forodesine hydrochloride
MUNDESINE
-
fosaprepitant meglumine
PROEMEND
-
freeze-dried polyethylene glycol-treated human normal immunoglobulin
KENKETU GLOVENIN-I PARTIAL CHANGE APPROVAL
-
freeze-dried smallpox vaccine prepared in cell culture
FREEZE-DRIED SMALLPOX VACCINE PREPARED IN CELL CULTURE LC16 “KMB” PARTIAL CHANGE APPROVAL
-
garenoxacin mesilate hydrate
GENINAX
-
gefapixant citrate
LYFNUA
-
gentian alkaline mixture
NULL
-
glecaprevir hydrate/pibrentasvir
MAVIRET
-
glycomacropeptide and essential amino acids with vitamins and minerals
PKU GLYTACTIN RTD 15
-
glycopyrronium bromide/ formoterol fumarate hydrate
BEVESPI AEROSPHERE
Frequently asked questions
How many pipeline drugs are listed?
1,610 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.